Skip to content

Healthcare Value Capital, LLC 13F Holdings · last filed Q3 2021

Healthcare Value Capital, LLC reported 18 securities worth $50.65M in its SEC 13F filing for Q3 2021 (period ended 2021-09-30). Top holdings: ALKS (12.18%), PFE (10.62%), GILD (8.27%). Among its top 25 positions this quarter: 3 new, 7 added, 4 trimmed, 2 exited.

RankTickerCompanyValue% PortfolioSharesAction
1ALKSALKERMES PLC$6.2M12.18%200,000Added
2PFEPFIZER INC$5.4M10.62%125,000Added
3GILDGILEAD SCIENCES INC$4.2M8.27%60,000Trimmed
4GSKGLAXOSMITHKLINE PLC$3.8M7.54%100,000Hold
5AMYTAMRYT PHARMA PLC$3.0M5.97%250,000Added
6AZNASTRAZENECA PLC$3.0M5.93%50,000Hold
7MRKMERCK & CO INC$3.0M5.93%40,000Hold
8BMYBRISTOL-MYERS SQUIBB CO$3.0M5.84%50,000Hold
9SPXUPROSHARES TR$2.6M5.19%150,000Added
10IRWDIRONWOOD PHARMACEUTICALS INC$2.6M5.16%200,000Trimmed
11CLVSCLOVIS ONCOLOGY INC$2.2M4.40%500,000Hold
12TYMETYME TECHNOLOGIES INC$2.1M4.07%2.0MAdded
13ATRSANTARES PHARMA INC$1.8M3.59%500,000Hold
14SQQQPROSHARES TR$1.7M3.41%200,000Added
15UVXYPROSHARES TR II$1.2M2.42%50,000New
16AMRNAMARIN CORP PLC$1.0M2.01%200,000Hold
17VRTXVERTEX PHARMACEUTICALS INC$907,0001.79%5,000New
18GNLNGREENLANE HLDGS INC$830,0001.64%350,000Hold
19VYNEVYNE THERAPEUTICS INC$556,0001.10%400,000Trimmed
20ADMSADAMAS PHARMACEUTICALS INC$491,0000.97%100,000Hold
21GMDAQGAMIDA CELL LTD$392,0000.77%100,000Added
22DRRXDURECT CORP$320,0000.63%250,000New
23VIXYPROSHARES TR II$285,0000.56%12,500Trimmed
24COLLCOLLEGIUM PHARMACEUTICAL INC$00.00%0Exited
25MDXGMIMEDX GROUP INC$00.00%0Exited

Source: SEC Form 13F filings · as of 2021-09-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR